Bonk (NASDAQ:BNKK – Get Free Report) released its earnings results on Wednesday. The company reported ($0.11) EPS for the quarter, Zacks reports.
Bonk Trading Down 1.4%
Shares of BNKK stock traded down $0.00 during mid-day trading on Wednesday, reaching $0.14. The stock had a trading volume of 1,682,225 shares, compared to its average volume of 5,320,803. The stock has a market capitalization of $24.36 million, a price-to-earnings ratio of -0.44 and a beta of 1.55. Bonk has a 52-week low of $0.13 and a 52-week high of $1.34.
Wall Street Analysts Forecast Growth
Separately, Weiss Ratings reissued a “sell (d-)” rating on shares of Bonk in a research note on Thursday, November 13th. One analyst has rated the stock with a Sell rating, According to MarketBeat, the stock presently has an average rating of “Sell”.
Bonk Company Profile
Safety Shot, Inc, a wellness and functional beverage company, engages in the research and development of over-the-counter products and intellectual property. Its products pipeline includes Photocil to address psoriasis and vitiligo; JW-700 to treat hair loss; JW-500 for women’s sexual wellness; NoStingz, a jellyfish sting prevention sunscreen; and JW-110 for the treatment of atopic dermatitis/eczema.
Featured Stories
- Five stocks we like better than Bonk
- Investing in Commodities: What Are They? How to Invest in Them
- onsemi Places a $6 Billion Bet on Its Own Stock
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- HIMS Has Been a Roller Coaster Ride. Should Investors Hop On?
- Basic Materials Stocks Investing
- End the Year Strong With These 3 Comeback Champions
Receive News & Ratings for Bonk Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bonk and related companies with MarketBeat.com's FREE daily email newsletter.
